EUVIMEDEUVIMED entdecken
Open Access

Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species

Muktha S Natrajan iD, Jesse M Hall, Michael R Weigand, Yanhui Peng, Margaret M Williams, Mohamed Momin, Frederick Heath Damron iD, Purnima Dubey, Maria Lucia Tondella, Lucia C Pawloski iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03527-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Muktha S Natrajan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Geor…. Hauptthemen laut MEDLINE: Whooping Cough. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, CDC Advanced Molecular Detection Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acellular pertussis vaccines protect against severe pertussis, but vaccine-induced immunity wanes over time. Prior animal studies showed that T-cell responses are integral to long-lasting immunity. Current pertussis vaccines also do not provide considerable protection against other species that cause pertussis-like illness, such as Bordetella parapertussis and Bordetella holmesii . We aimed to identify potential vaccine antigens from conserved orthologs that are predicted to engage CD4 T cells and provide cross-protective immunity against multiple Bordetella pathogens. Whole-genome sequence data were previously collected for Bordetella pertussis , B. parapertussis , and B. holmesii isolates. Immunoinformatics and comparative genomics were used to predict immunogenicity, cross-reactive proteins, and protein homology for a set of Bordetella isolates. Expression and production levels of homologous, immunogenic targets were screened using transcriptomic and proteomic data, and detectable genes were analyzed by reverse transcription quantitative PCR. Computational prediction methods identified putative human leukocyte antigen-DR-binding epitopes. Recognition of targets by T cells from individuals immunized with whole-cell pertussis vaccines was confirmed ex vivo . From the B. pertussis genome, 408 genes exhibited high sequence conservation with orthologs in B. parapertussis and B. holmesii , and a select group had high immunogenicity scores. A subset of detectable proteins were also Bordetella -specific and non-cross-reactive. Epitope mapping predicted 36 conserved, immunogenic, and naturally processed epitopes. Of these 36 targets, six epitopes upregulated markers of T-cell activation, and three elicited cytokine production. Our findings identified a list of peptides specific to Bordetella respiratory pathogens that may confer long-lasting, cross-protective T-cell immunity. IMPORTANCE Pertussis, caused by Bordetella pertussis , can cause debilitating respiratory symptoms, so whole-cell pertussis vaccines (wPVs) were introduced in the 1940s. However, reactogenicity of wPV necessitated the development of acellular pertussis vaccines (aPVs) that were introduced in the 1990s. Since then, until the COVID-19 pandemic began, reported pertussis incidence was increasing, suggesting that aPVs do not induce long-lasting immunity and may not effectively prevent transmission. Additionally, aPVs do not provide protection against other Bordetella species that are observed during outbreaks. The significance of this work is in determining potential new vaccine antigens for multiple Bordetella species that are predicted to elicit long-term immune responses. Genome-based approaches have aided the development of novel vaccines; here, these methods identified Bordetella vaccine candidates that may be cross-protective and predicted to induce strong memory responses. These targets can lead to an improved vaccine with a strong safety profile while also strengthening the longevity of the immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whooping CoughHumansEpitopesPandemicsVaccines, AcellularBordetella pertussisPertussis VaccineHLA-DR Antigens

Stichwörter der Autor:innen

Bordetella pertussiscross-protectionepitope vaccinesimmunogenicity

Substanzen

EpitopesVaccines, AcellularPertussis VaccineHLA-DR Antigens

Autor:innen und Institutionen

  • Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • Laboratory Leadership Service, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University , Columbus, Ohio, USA.
  • Department of Microbiology, Immunology, and Cell Biology, West Virginia University , Morgantown, West Virginia, USA.

ORCID-Profile: Muktha S Natrajan, Frederick Heath Damron, Lucia C Pawloski

Förderung

  • NIAID NIH HHS
  • CDC Advanced Molecular Detection Program

Zitieren

APA

Natrajan, M. S., Hall, J. M., Weigand, M. R., Peng, Y., Williams, M. M., Momin, M., Damron, F. H., Dubey, P., Tondella, M. L., & Pawloski, L. C. (2024). Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03527-23

Vancouver

Natrajan MS, Hall JM, Weigand MR, Peng Y, Williams MM, Momin M, et al. Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03527-23

BibTeX
@article{Natrajan2024,
  author = {Natrajan, Muktha S and Hall, Jesse M and Weigand, Michael R and Peng, Yanhui and Williams, Margaret M and Momin, Mohamed and Damron, Frederick Heath and Dubey, Purnima and Tondella, Maria Lucia and Pawloski, Lucia C},
  title = {Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03527-23}
}
Kostenlos starten →